Biosimilar Growth Hormones: A Leading Driver Behind Rising Incidence Of Childhood Growth Hormone Deficiency Spurs Global Biosimilar Growth Hormone Market Market Expansion in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Biosimilar Growth Hormones Industry Market Size Be by 2025?
The market for biosimilar growth hormones has seen robust expansion in previous years. The size is anticipated to increase from $0.76 billion in 2024 to $0.82 billion in 2025, with a compound annual growth rate (CAGR) of 8.4%. This growth in the historic period is due to the surging demand for growth hormones, expiry of patents, established clinical evidence, and the rise in clinical trials.

What's the Long-Term Growth Forecast for the Biosimilar Growth Hormones Market Size Through 2029?
Expectations are high for a substantial expansion in the biosimilar growth hormones market over the upcoming years. Predictions suggest it will expand to a size of $1.19 billion by 2029, with a compound annual growth rate (CAGR) of 9.8%. The forecasted growth in this period is due to factors such as pediatric growth concerns, enhanced indications, increased diagnostic procedures, and a heightened understanding of biosimilar alternatives. Noteworthy developments in the forecast period encompass a strong focus on pediatric biosimilars, combinations of biosimilars, and improved dosing convenience.

View the full report here:
https://www.thebusinessresearchcompany.com/report/biosimilar-growth-hormone-global-market-report

What Are the Key Growth Drivers Fueling the Biosimilar Growth Hormones Market Expansion?
An increasing prevalence of growth hormone deficiency amongst children is driving the expansion of the global biosimilar growth hormone market. Growth hormone deficiencies arise due to damage to the hypothalamus or pituitary gland, which can be the result of a congenital abnormality or an issue that occurred during or post birth. In an example, Hormones Australia, the Australia-based authority for endocrine related conditions, confirmed in September 2023 that the Endocrine Society of Australia (ESA) estimates that growth hormone deficiency will impact 2 to 3 of every 10,000 people. Consequently, the escalation in growth deficiencies in children bolsters the development of the biosimilar growth hormones sector.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3391&type=smp

What Are the Key Trends Driving Biosimilar Growth Hormones Market Growth?
In the biosimilar growth hormones market, top operators like Pfizer Inc and OPKO Health Inc, both based in the US, are pioneering solutions - such as human growth hormone - devised to boost the efficacy and affordability of treating growth hormone deficiencies. These novel solutions consist of medical treatments or supplements that can either stimulate or replace human growth hormone (HGH) in the body, either for the purpose of addressing growth deficiencies or for anti-aging. As an example, these two companies received approval from the US Food and Drug Administration (FDA) in June 2023 for NGENLA (somatrogon-ghla), a new weekly injection regimen for human growth hormone treatment specifically for children suffering from growth hormone deficiency (GHD). This innovative, long-lasting growth hormone therapy replaces daily shots, providing relief and convenience for both patients and their caregivers. FDA approval emerged following clinical research which confirmed its efficacy and safety, thereby marking a significant step forward in growth hormone therapies.

How Is the Biosimilar Growth Hormones Market Segmented?
The biosimilar growth hormones market covered in this report is segmented -

1) By Route Of Administration: Intravenous, Subcutaneous, Intramuscular, Oral
2) By Application: Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature, Prader Willi Syndrome, Other Applications
3) By Distribution Channel: Hospital And Retail Pharmacy, Online Pharmacy/ePharmacy, Specialty Clinics

Subsegments:
1) By Intravenous: Hospital-based Administration, Outpatient Clinics
2) By Subcutaneous: Self-administration, Professional Administration
3) By Intramuscular: Pediatric Care, Adult Care
4) By Oral: Tablets, Capsules

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=3391&type=smp

Which Companies Are Leading the Charge in Biosimilar Growth Hormones Market Innovation?
Major companies operating in the biosimilar growth hormones market include Amega Biotech, Biosidus S.A., Eli Lilly and Company, Ferring Pharmaceuticals, Genetech Inc., Merck & Co. Inc., Novartis AG, Novo Nordisk A/S, Sanofi S.A., USV Private Limited, Zhongshan Hygene Biopharm Co. Ltd., Biopartners And LG Chem, Boehringer Ingelheim International GmbH, Celltrion Inc., Dr. Reddy's Laboratories Ltd., Gedeon Richter Plc., Genor Biopharma Co. Ltd., Hetero Drugs Limited, Intas Pharmaceuticals Ltd., LG Chem Ltd., Lupin Limited, Mabion S.A., Mundipharma International Limited, Panacea Biotec Limited, Pfenex Inc., PlantForm Corporation

Which Regions Are Leading the Global Biosimilar Growth Hormones Market in Revenue?
The countries covered in the biosimilar growth hormones market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3391

"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.